Evidence map›Paper›PMID 27170414›Full record

SynthesisScientific reports2016

Comparative study of serum zinc concentrations in benign and malignant prostate disease: A Systematic Review and Meta-Analysis.

Jiang Zhao, Qingjian Wu, Xiaoyan Hu, Xingyou Dong, Liang Wang, Qian Liu, Zhou Long, Longkun Li

Erratum issuedOpen access · goldAbstract readComparative StudyMeta-AnalysisSystematic Review
In one paragraph

Synthesis in Scientific reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 22 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 2 pooled it
2.5field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 2 syntheses or guidelines pooled it, 46 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Observational
  8. Review
  9. Review
  10. Article
  11. Review
  12. Bioactive materials · 2022
    Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Review
  18. Advances of Zinc Signaling Studies in Prostate Cancer.International journal of molecular sciences · 2020
    Review
  19. Development of Zinc-Specific iCEST MRI as an Imaging Biomarker for Prostate Cancer.Angewandte Chemie (International ed. in English) · 2019
    Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Jiang ZhaoDepartment of Urology, Second Affiliated Hospital, Third Military Medical University, Chongqing, 400037, China.
Qingjian WuDepartment of Urology, Second Affiliated Hospital, Third Military Medical University, Chongqing, 400037, China.
Xiaoyan HuDepartment of Urology, Second Affiliated Hospital, Third Military Medical University, Chongqing, 400037, China.
Xingyou DongDepartment of Urology, Second Affiliated Hospital, Third Military Medical University, Chongqing, 400037, China.
Liang WangDepartment of Urology, Second Affiliated Hospital, Third Military Medical University, Chongqing, 400037, China.
Qian LiuDepartment of Urology, Second Affiliated Hospital, Third Military Medical University, Chongqing, 400037, China.
Zhou LongDepartment of Urology, Second Affiliated Hospital, Third Military Medical University, Chongqing, 400037, China.
Longkun LiDepartment of Urology, Second Affiliated Hospital, Third Military Medical University, Chongqing, 400037, China.
Army Medical University · CNXinqiao Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Many studies have investigated the relationship between serum zinc concentration and prostatic disease, but have shown inconsistent results. Hence, we performed a systematic literature review and meta-analysis to assess the correlation between serum zinc concentration and prostate disease. Systematic literature searches were conducted with PubMed, EMBASE, Science Direct/Elsevier, MEDLINE, CNKI and the Cochrane Library up to June 2015 for studies that involved the relationship between serum zinc concentration and prostate disease. Fourteen studies were identified from the databases. Our results illustrated that the serum zinc concentrations in prostate cancer patients were significantly lower than those in Benign prostatic hyperplasia (BPH) patients and normal controls (SMD (95% CI), -0.94 [-1.57, -0.32]; -1.18 [-1.90, -0.45]). However, the serum zinc concentrations in BPH patients were significantly higher than those in normal controls (SMD (95% CI) 1.77 [0.15, 3.39]). The present study showed that different levels of serum zinc concentrations are correlated with different prostatic disease. Serum zinc concentration may be used as a tool for the diagnosis and screening of prostate disease. But, further studies with well-designed larger sample studies are needed in this field to further clarify the correlation between serum zinc concentration and prostate disease.

Indexed as

AgedHumansMaleMiddle AgedProstatic HyperplasiaProstatic NeoplasmsPublication BiasSensitivity and SpecificityZincZinc

Identifiers

PMID27170414
PMCPMC4864417
OpenAlexW2348094781

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.